Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Atyr Pharma Inc (LIFE)

Atyr Pharma Inc (LIFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 41,104
  • Shares Outstanding, K 9,537
  • Annual Sales, $ 420 K
  • Annual Income, $ -23,600 K
  • 60-Month Beta 2.14
  • Price/Sales 95.37
  • Price/Cash Flow N/A
  • Price/Book 1.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.74
  • Number of Estimates 3
  • High Estimate -0.67
  • Low Estimate -0.82
  • Prior Year -1.47
  • Growth Rate Est. (year over year) +49.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.57 +20.73%
on 09/11/20
4.66 -7.41%
on 08/20/20
-0.08 (-1.82%)
since 08/18/20
3-Month
3.50 +23.13%
on 08/13/20
5.48 -21.35%
on 07/20/20
+0.39 (+9.95%)
since 06/18/20
52-Week
2.13 +102.35%
on 03/19/20
7.62 -43.44%
on 01/06/20
+0.45 (+11.66%)
since 09/18/19

Most Recent Stories

More News
At 10.30% CAGR, Heart Valve Repair And Replacement Market Size | Share, Trends, Growth | Research Development Report To 2025

BSX : 38.48 (-3.00%)
CRY : 17.38 (+3.82%)
LIFE : 4.31 (+2.13%)
MDT : 107.60 (-0.19%)
NVCN.TO : 2.84 (-1.05%)
STJ : 80.82 (+0.16%)
At 10.5% CAGR, Heart Valve Repair and Replacement Market Share, Current Trends and Research Development Report to 2025 | Covid-19 Impact Analysis

BSX : 38.48 (-3.00%)
CRY : 17.38 (+3.82%)
LIFE : 4.31 (+2.13%)
MDT : 107.60 (-0.19%)
NVCN.TO : 2.84 (-1.05%)
STJ : 80.82 (+0.16%)
aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Doses First Subjects in Phase 1 Trial of ATYR1923 in Japan

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that its partner Kyorin...

LIFE : 4.31 (+2.13%)
aTyr Pharma Announces $20 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC

Aspire Capital commits to purchase up to $20 Million of Common Stock over a period of up to 30 months.

LIFE : 4.31 (+2.13%)
Prosthetic Heart Valve Market Report 2020 - Covering Impact of COVID-19, Financial Information, Developments, SWOT Analysis by Global Top Companies By 2025

The Global is expected to exceed more than USD$ 4 Billion by 2024; Growing at a CAGR of more than 9% in the given forecast period.

ABT : 106.86 (+0.19%)
BSX : 38.48 (-3.00%)
CRY : 17.38 (+3.82%)
EW : 83.20 (-0.59%)
LIFE : 4.31 (+2.13%)
NVCN.TO : 2.84 (-1.05%)
STJ : 80.82 (+0.16%)
aTyr Pharma to Present at September Investor Conferences

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that the company will...

MHMNF : 54.5000 (unch)
LIFE : 4.31 (+2.13%)
World High Life Investment Strategy Update

Love Hemp momentum provides World High Life team with the opportunity to focus investment attention on innovative applications for medicinal cannabis, including synthetics, CBD, and Hemp

LIFE : 4.31 (+2.13%)
WRHLF : 0.0250 (-24.24%)
World High Life PLC Announces Investment Strategy Update

LIFE : 4.31 (+2.13%)
WRHLF : 0.0250 (-24.24%)
aTyr Pharma to Present at Life Sciences Investor Forum on September 17th

aTyr Pharma, Inc. (the "Company") (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that...

LIFE : 4.31 (+2.13%)
GPS Tracking Software Market Report 2020 by Size, Share, Trends, Growth and Outlook with Company Analysis and Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

The global GPS Tracking Software market focuses on encompassing major statistical evidence for the GPS Tracking Software industry as it offers our readers a value addition on guiding them in encountering...

A : 99.38 (-0.22%)
AMRI : 21.74 (unch)
COTXF : 1.5400 (unch)
LIFE : 4.31 (+2.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade LIFE with:

Business Summary

aTyr Pharma, Inc. is a bio-therapeutics company. The Company is involved in the discovery and development of medicines for severe, rare diseases of physiological modulators. aTyr Pharma, Inc. is a based in SAN DIEGO, United States.

See More

Key Turning Points

2nd Resistance Point 4.44
1st Resistance Point 4.37
Last Price 4.31
1st Support Level 4.22
2nd Support Level 4.14

See More

52-Week High 7.62
Fibonacci 61.8% 5.52
Fibonacci 50% 4.88
Last Price 4.31
Fibonacci 38.2% 4.23
52-Week Low 2.13

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar